MapLight Therapeutics, Inc.
MapLight Therapeutics, Inc. (MPLT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mplt · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for MapLight Therapeutics, Inc. (MPLT) measures how much investors pay for each dollar of the company's trailing earnings. MPLT's current PE ratio of N/A is calculated by dividing its stock price of $30.05 by its TTM earnings per share of -$4.41.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2022 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MapLight Therapeutics, Inc.You MPLT | $24M | N/A | — | -$4.41 |
 BioRestorative Therapies, Inc. BRTX | $3M | N/A | — | -$1.58 |
 Dogwood Therapeutics, Inc. DWTX | $3M | N/A | — | -$4.17 |
 Edesa Biotech, Inc. EDSA | $48M | N/A | — | -$1.27 |
 Ernexa Therapeutics Inc. ERNA | $2M | N/A | — | -$55.83 |
 Immuron Limited IMRN | $7M | N/A | — | -$0.90 |
 Lipocine Inc. LPCN | $12M | N/A | — | -$1.77 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.66 | — | |
2024-12-31 FY2024 | — | $-1.87 | — | |
2023-12-31 FY2023 | — | $-1.34 | — | |
2022-12-31 FY2022 | — | $-0.72 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MapLight Therapeutics, Inc. (MPLT) measures how much investors pay for each dollar of the company's trailing earnings. MPLT's current PE ratio of N/A is calculated by dividing its stock price of $30.05 by its TTM earnings per share of -$4.41.
Frequently asked questions
MPLT pe ratio · 6 questionsMPLT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $30.05 and TTM EPS of -$4.41. Data sourced from Financial Modeling Prep via MPLT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MapLight Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09